Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carol Matyka"'
Autor:
Charlotte Ouimet, Nora Hutchinson, Catherine Wang, Carol Matyka, Joseph C. Del Paggio, Jonathan Kimmelman
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Patients endure risk and uncertainty when they participate in clinical trials. We previously estimated that 12,217 patient-participants are required to bring a new cancer drug to market. However, many development efforts are aimed at extendi
Externí odkaz:
https://doaj.org/article/4e4333c0d0524cfaa0cdb75279358628
Autor:
Wendy Y. Chen, Karla V. Ballman, Eric P. Winer, Thomas H. Openshaw, Olwen Mary Hahn, Frederick M. Briccetti, William Johnson Irvin, Paula R Pohlmann, Lisa A. Carey, Ann H. Partridge, Anna Weiss, Linda Mackie McCall, Carol Matyka, Margaret Carvan, Michelle D. Holmes
Publikováno v:
Journal of Clinical Oncology. 40:360922-360922
360922 Background: In-vitro and in-vivo evidence suggests that aspirin may have an anti-tumor effect. Multiple epidemiologic studies have reported improved breast cancer survival among regular aspirin users compared to non-users. Pooled data from ran
Autor:
Michelle D. Holmes, Thomas H. Openshaw, Carol Matyka, Banu Symington, Lisa A. Carey, Eric P. Winer, Wendy Y. Chen, Margaret Carvan, Karla V. Ballman, Ann H. Partridge, Kala Visvanathan
Publikováno v:
Journal of Clinical Oncology. 38:TPS600-TPS600
TPS600 Background: In-vitro and in-vivo evidence suggest that aspirin may have an anti-tumor effect. Multiple epidemiologic studies have reported improved breast cancer survival among regular aspirin users compared to non-users. Pooled data from rand
Autor:
Wendy Y. Chen, Eric P. Winer, Karla V. Ballman, Ann H. Partridge, Lisa A. Carey, Margaret Carvan, Carol Matyka, Kala Visvanathan, Banu Symington, Michelle D. Holmes
Publikováno v:
Journal of Clinical Oncology. 37:TPS599-TPS599
TPS599 Background: In-vitro and in-vivo evidence suggest that aspirin may have an anti-tumor effect. Multiple epidemiologic studies have reported improved breast cancer survival among regular aspirin users compared to non-users. Pooled data from rand
Autor:
Wendy Y. Chen, Eric P. Winer, William Thomas Barry, Ann H. Partridge, Lisa A. Carey, Margaret Carvan, Carol Matyka, Kala Visvanathan, Banu Symington, Michelle D. Holmes
Publikováno v:
Journal of Clinical Oncology. 36:TPS597-TPS597
Autor:
Eric P. Winer, William T. Barry, Carol Matyka, Wendy Y. Chen, Michelle D. Holmes, Banu Symington, Clifford A. Hudis, Kala Visvanathan, Thomas H. Openshaw
Publikováno v:
Journal of Clinical Oncology. 35:TPS586-TPS586
TPS586 Background: In-vitro and in-vivo evidence suggest that aspirin, an inexpensive and widely available drug may have anti-tumor activity via effects on multiple pathways. Multiple epidemiologic studies have reported improved breast cancer surviva